Literature DB >> 10517899

Morphological and functional restoration of parietal cells in helicobacter pylori associated enlarged fold gastritis after eradication.

Y Murayama1, J Miyagawa, Y Shinomura, S Kanayama, Y Yasunaga, H Nishibayashi, K Yamamori, Y Higashimoto, Y Matsuzawa.   

Abstract

BACKGROUND/AIM: Helicobacter pylori infections are associated with hypochlorhydria in patients with pangastritis. It has previously been shown that eradication of H pylori leads to an increase in acid secretion in H pylori associated enlarged fold gastritis, suggesting that H pylori infection affects parietal cell function in the gastric body. The aim of this study was to evaluate the effects of H pylori infection on parietal cell morphology and function in hypochlorhydric patients. PATIENTS/
METHODS: The presence of H pylori infection, mucosal length, and inflammatory infiltration were investigated in six patients with enlarged fold gastritis and 12 patients without enlarged folds. Parietal cell morphology was examined by immunohistochemistry using an antibody against the alpha subunit of H(+),K(+)-ATPase and electron microscopy. In addition, gastric acid secretion and fasting serum gastrin concentration were determined before and after the eradication of H pylori.
RESULTS: In the H pylori positive patients with enlarged fold gastritis, fold width, foveolar length, and inflammatory infiltration were increased. In addition, the immunostaining pattern of H(+), K(+)-ATPase was less uniform, and the percentage of altered parietal cells showing dilated canaliculi with vacuole-like structures and few short microvilli was greatly increased compared with that in H pylori positive patients without enlarged folds. After eradication, fold width, foveolar length, and inflammatory infiltrates decreased and nearly all parietal cells were restored to normal morphology. On the other hand, altered parietal cells were negligible in H pylori negative patients. In addition, the basal acid output and tetragastrin stimulated maximal acid output increased significantly from 0.5 (0.5) to 4.1 (1.5) mmol/h and from 2.5 (1.2) to 13.8 (0.7) mmol/h (p<0.01), and fasting serum gastrin concentrations decreased significantly from 213.5 (31.6) to 70.2 (7.5) pg/ml (p<0.01) after eradication in patients with enlarged fold gastritis.
CONCLUSION: The morphological changes in parietal cells associated with H pylori infection may be functionally associated with the inhibition of acid secretion seen in patients with enlarged fold gastritis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517899      PMCID: PMC1727706          DOI: 10.1136/gut.45.5.653

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  37 in total

1.  Hyperplastic gastropathy. Clinicopathologic correlation.

Authors:  R A Komorowski; J G Caya
Journal:  Am J Surg Pathol       Date:  1991-06       Impact factor: 6.394

Review 2.  The Sydney System: histological division.

Authors:  A B Price
Journal:  J Gastroenterol Hepatol       Date:  1991 May-Jun       Impact factor: 4.029

3.  Enlarged gastric folds in association with Campylobacter pylori gastritis.

Authors:  S Morrison; B B Dahms; E Hoffenberg; S J Czinn
Journal:  Radiology       Date:  1989-06       Impact factor: 11.105

4.  Lymphocytic gastritis: a newly described entity: a retrospective endoscopic and histological study.

Authors:  J Haot; L Hamichi; L Wallez; P Mainguet
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

5.  Secretagogue-specific effects of interleukin-1 on gastric acid secretion.

Authors:  J L Wallace; M Cucala; K Mugridge; L Parente
Journal:  Am J Physiol       Date:  1991-10

6.  Menetrier's disease: a form of hypertrophic gastropathy or gastritis?

Authors:  H C Wolfsen; H A Carpenter; N J Talley
Journal:  Gastroenterology       Date:  1993-05       Impact factor: 22.682

7.  Giant fold gastritis--a special form of Helicobacter pylori associated gastritis.

Authors:  M Stolte; C Bätz; S Eidt
Journal:  Z Gastroenterol       Date:  1993-05       Impact factor: 2.000

8.  Helicobacter pylori infection and the risk of gastric carcinoma.

Authors:  J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

9.  Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying.

Authors:  A Robert; A S Olafsson; C Lancaster; W R Zhang
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

10.  Characterization of human autoantibodies reactive to gastric parietal cells.

Authors:  X H Wang; Y Miyazaki; Y Shinomura; Y Moriyama; R K Nakamoto; Y Matsuzawa; M Maeda; M Futai
Journal:  Biochem Biophys Res Commun       Date:  1993-01-15       Impact factor: 3.575

View more
  8 in total

1.  Dynamic functional and ultrastructural changes of gastric parietal cells induced by water immersion-restraint stress in rats.

Authors:  Yu-Mei Li; Guo-Ming Lu; Xiao-Ping Zou; Zhao-Shen Li; Gui-Yong Peng; Dian-Chun Fang
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

2.  Helicobacter pylori eradication improved the Kyoto classification score on endoscopy.

Authors:  Osamu Toyoshima; Toshihiro Nishizawa; Kosuke Sakitani; Tadahiro Yamakawa; Yoshiyuki Takahashi; Kazunori Kinoshita; Akira Torii; Atsuo Yamada; Hidekazu Suzuki; Kazuhiko Koike
Journal:  JGH Open       Date:  2020-05-29

Review 3.  Helicobacter pylori infection in functional dyspepsia.

Authors:  Hidekazu Suzuki; Paul Moayyedi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-29       Impact factor: 46.802

4.  Ghrelin cells in the gastrointestinal tract.

Authors:  Ichiro Sakata; Takafumi Sakai
Journal:  Int J Pept       Date:  2010-03-14

5.  Should we still subcategorize helicobacter pylori-associated dyspepsia as functional disease?

Authors:  Kentaro Sugano
Journal:  J Neurogastroenterol Motil       Date:  2011-10-31       Impact factor: 4.924

6.  Chronic in vivo exposure to Helicobacter pylori VacA: Assessing the efficacy of automated and long-term intragastric toxin infusion.

Authors:  Robin L Holland; Kristopher D Bosi; Gregory H Harpring; Jiayi Luo; Matthew Wallig; Heidi Phillips; Steven R Blanke
Journal:  Sci Rep       Date:  2020-06-09       Impact factor: 4.379

7.  Nodular gastritis in association with gastric cancer development before and after Helicobacter pylori eradication.

Authors:  Izumi Nishikawa; Jun Kato; Satoshi Terasoma; Hiroyoshi Matsutani; Hidehiko Tamaki; Tetsuya Tamaki; Fumiaki Kuwashima; Hiroya Nakata; Tatsuji Tomeki; Hideyuki Matsunaka; Yumiko Ibata; Yasunobu Yamashita; Takao Maekita; Katsuhiko Higashi; Masao Ichinose
Journal:  JGH Open       Date:  2018-03-25

8.  Consistency between the endoscopic Kyoto classification and pathological updated Sydney system for gastritis: A cross-sectional study.

Authors:  Osamu Toyoshima; Toshihiro Nishizawa; Shuntaro Yoshida; Tatsuya Matsuno; Nariaki Odawara; Akira Toyoshima; Kosuke Sakitani; Hidenobu Watanabe; Mitsuhiro Fujishiro; Hidekazu Suzuki
Journal:  J Gastroenterol Hepatol       Date:  2021-10-06       Impact factor: 4.369

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.